References
- RuddRAAleshireNZibbellJEGladdenRMIncreases in drug and opioid overdose deaths — United States, 2000–2014MMWR Morb Mortal Wkly Rep20166450–511378138226720857
- Center for Behavioral Health Statistics and Quality2014 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration2015 Available from: http://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs2014/NSDUH-DetTabs2014.pdfAccessed October 28, 2016
- FDA guidance on abuse-deterrent opioids — evaluation and labeling Available from: http://www.fda.gov/RegulatoryInformation/Guidances/default.htmAccessed October 29, 2016
- WarnerMHedegaardHChenLHTrends in Drug-Poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 1999–20122014 Available from: https://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_poisoning_deaths_1999-2012.pdfAccessed October 29, 2016
- Opioid abuse task forceAssembly Committee on Health, AB1977 (Wood)-Amended April 132016 Available from: www.legtrack.com/cache/285312.docAccessed November 2, 2016
- FDA Facts Abuse-Deterrent Opioid Medications Available from: http://www.fda.gov/NewsEvents/Newsroom/FactSheets/ucm514939.htmAccessed November 2, 2016
- DEA Reduces amount of opioid controlled substances to be manufactured in 2017 Available from: https://www.dea.gov/divisions/hq/2016/hq100416.shtmlAccessed October 29, 2016
- LevyBPaulozziLMackKAJonesCMTrends in opioid analgesic-prescribing rates by specialty, U.S., 2007–2012Am J Prev Med201549340941325896191
- DartRCSurrattHLCiceroTJTrends in opioid analgesic abuse and mortality in the United StatesN Engl J Med2015372324124825587948
- CiceroTJEllisMSAbuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContinJAMA Psychiat2015725424429
- JohnsonHPaulozziLPorucznikCMackKHerterBDecline in drug overdose deaths after state policy changes – Florida, 2010–2012MMWR Morb Mortal Wkly Rep2014632656957424990490
- ComptonWMJonesCMBaldwinGTRelationship between nonmedical prescription-opioid use and heroin useN Engl J Med2016374215416326760086
- Centers for Disease Control and PreventionInflux of Fentanyl-Laced Counterfeit Pills and Toxic Fentanyl-Related Compounds Further Increases Risk of Fentanyl-Related Overdose and Fatalities. HAN Health Advisory2016 Available from: http://health.mo.gov/emergencies/ert/alertsadvisories/pdf/cdc-update82616.pdfAccessed October 29, 2016
- SmithPC1SchmidtSMAllensworth-DaviesDSaitzRA single-question screening test for drug use in primary careArch Intern Med2010170131155116020625025
- HaffajeeRLJenaABWeinerSGMandatory use of prescription drug monitoring programsJAMA2015313989189225622279
- NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain2014Bethesda, MD Available from: https://prevention.nih.gov/docs/programs/p2p/OpioidPainTreatmnt_Program-Book.pdfAccessed November 2, 2016
- VolkowNDMcLellanATOpioid abuse in chronic pain – misconceptions and mitigation strategiesN Engl J Med2016374131253126327028915
- State Naloxone and Good Samaritan Legislation, December, 2015 Available from: https://www.whitehouse.gov/sites/default/files/ondcp/Blog/naloxonecirclechart_january2016.pdfAccessed October 16, 2016